These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1362129)

  • 1. Expression, purification, and characterization of Bacneu. A soluble protein tyrosine kinase domain encoded by the neu-oncogene.
    Myers JN; LeVea CM; Smith JE; Kallen RG; Tung L; Greene MI
    Receptor; 1992; 2(1):1-16. PubMed ID: 1362129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, purification and characterization of focal adhesion kinase using a baculovirus system.
    Withers BE; Keller PR; Fry DW
    Protein Expr Purif; 1996 Feb; 7(1):12-8. PubMed ID: 9172776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
    Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, and characterization of the cytoplasmic domain of the human IGF-1 receptor using a baculovirus expression system.
    Tennagels N; Hube-Magg C; Wirth A; Noelle V; Klein HW
    Biochem Biophys Res Commun; 1999 Jul; 260(3):724-8. PubMed ID: 10403833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active recombinant human tyrosine kinase c-Yes: expression in baculovirus system, purification, comparison to c-Src, and inhibition by a c-Src inhibitor.
    Susa M; Luong-Nguyen NH; Crespo J; Maier R; Missbach M; McMaster G
    Protein Expr Purif; 2000 Jun; 19(1):99-106. PubMed ID: 10833396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activity.
    Hsu CY; Mohammadi M; Nathan M; Honegger A; Ullrich A; Schlessinger J; Hurwitz DR
    Cell Growth Differ; 1990 Apr; 1(4):191-200. PubMed ID: 2083199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, purification, and initial characterization of human Yes protein tyrosine kinase from a bacterial expression system.
    Sun G; Budde RJ
    Arch Biochem Biophys; 1997 Sep; 345(1):135-42. PubMed ID: 9281320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
    Tarakhovsky A; Zaichuk T; Prassolov V; Butenko ZA
    Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein.
    Juang SH; Carvajal ME; Whitney M; Liu Y; Carraway CA
    Oncogene; 1996 Mar; 12(5):1033-42. PubMed ID: 8649794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TPA inhibits the tyrosine kinase activity of the neu protein in vivo and in vitro.
    Cao H; Decker S; Stern DF
    Oncogene; 1991 May; 6(5):705-11. PubMed ID: 1675782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transforming mutation enhances the activity of the c-Kit soluble tyrosine kinase domain.
    Lam LP; Chow RY; Berger SA
    Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):131-8. PubMed ID: 9931308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2.
    Wildenhain Y; Pawson T; Blackstein ME; Andrulis IL
    Oncogene; 1990 Jun; 5(6):879-83. PubMed ID: 1694290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of autophosphorylation in modulation of erbB-2 transforming function.
    Segatto O; Lonardo F; Pierce JH; Bottaro DP; Di Fiore PP
    New Biol; 1990 Feb; 2(2):187-95. PubMed ID: 1982072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: a possible role for tyrosine kinases.
    Reyes-Cruz G; Vázquez-Prado J; Müller-Esterl W; Vaca L
    J Cell Biochem; 2000 Jan; 76(4):658-73. PubMed ID: 10653985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM; Carpenter G
    J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and enzyme activity of ACK1.
    Yokoyama N; Miller WT
    Methods Enzymol; 2006; 406():250-60. PubMed ID: 16472662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.